CollPlant Biotechnologies (CLGN) Long-Term Deferred Tax (2020 - 2022)

CollPlant Biotechnologies' Long-Term Deferred Tax history spans 3 years, with the latest figure at $23.1 million for Q4 2022.

  • For Q4 2022, Long-Term Deferred Tax rose 45.99% year-over-year to $23.1 million; the TTM value through Dec 2022 reached $23.1 million, up 45.99%, while the annual FY2022 figure was $23.1 million, 45.99% up from the prior year.
  • Long-Term Deferred Tax reached $23.1 million in Q4 2022 per CLGN's latest filing, up from $15.8 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $23.1 million in Q4 2022 to a low of $15.5 million in Q4 2020.
  • Average Long-Term Deferred Tax over 3 years is $18.1 million, with a median of $15.8 million recorded in 2021.
  • Peak YoY movement for Long-Term Deferred Tax: increased 2.0% in 2021, then skyrocketed 45.99% in 2022.
  • A 3-year view of Long-Term Deferred Tax shows it stood at $15.5 million in 2020, then increased by 2.0% to $15.8 million in 2021, then skyrocketed by 45.99% to $23.1 million in 2022.
  • Per Business Quant, the three most recent readings for CLGN's Long-Term Deferred Tax are $23.1 million (Q4 2022), $15.8 million (Q4 2021), and $15.5 million (Q4 2020).